SC
PRAX icon

SummitTX Capital’s Praxis Precision Medicines PRAX Stock Holding History

SummitTX Capital’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.62M Sell
19,779
-17,059
-46% -$5.4M 0.17% 152
2026
Q1 		$11.9M Sell
36,838
-4,791
-12% -$1.48M 0.37% 46
2025
Q4 		$12.3M Buy
41,629
+6,701
+19% +$1.25M 0.37% 53
2025
Q3 		$1.85M Buy
+34,928
New +$1.69M 0.08% 270

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

SummitTX Capital's PRAX Position: Q2 2026 in Review

SummitTX Capital reduced its Praxis Precision Medicines (PRAX) stake by 46% in Q2 2026, selling an estimated $5.4M and leaving 19,779 shares worth $6.62M. The position accounts for 0.17% of the portfolio, ranked #152.

SummitTX Capital first reported a position in PRAX in Q3 2025 and has held it in 4 quarters since. The position peaked at $12.3M in Q4 2025. 310 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • SummitTX Capital held 19,779 shares of Praxis Precision Medicines worth $6.62M as of Q2 2026.
  • SummitTX Capital sold 17,059 Praxis Precision Medicines shares in Q2 2026, an estimated $5.4M.
  • Praxis Precision Medicines made up 0.17% of SummitTX Capital's portfolio in Q2 2026, its #152 holding.
  • SummitTX Capital first reported a position in Praxis Precision Medicines in Q3 2025 and has held it in 4 quarters since.
  • SummitTX Capital's Praxis Precision Medicines position peaked at $12.3M in Q4 2025.
  • 310 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on SummitTX Capital's 13F filing for Q2 2026, filed 14 Aug 2026.